Viewing StudyNCT00193622



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00193622
Status: COMPLETED
Last Update Posted: 2010-09-17
First Post: 2005-09-12

Brief Title: Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
Sponsor:
Organization: SCRI Development Innovations LLC